ASXC Insider Trading Activity and SEC Form 4 Filings
ASXC insider trading summary
No open-market insider purchases or sales of Asensus Surgical, Inc. (ASXC) have been reported on SEC Form 4 in the past 12 months.
Latest ASXC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 14, 2023 | William N Starling JR | Director | Sell | $5K (18,134 @ $0.28) |
| Dec 14, 2023 | William N Starling JR | Director | Buy | $5K (18,134 @ $0.28) |
| Mar 3, 2023 | Andrea Biffi | Director | Buy | $208K (293,077 @ $0.71) |
| Jun 13, 2022 | William N Starling JR | Director | Sell | $11K (27,010 @ $0.40) |
| Mar 15, 2022 | Elizabeth Kwo | Director | Buy | $10K (18,000 @ $0.53) |
| Mar 7, 2022 | David Bruce Milne | Director | Buy | $62K (100,000 @ $0.62) |
| Mar 7, 2022 | David Bruce Milne | Director | Buy | $44K (69,232 @ $0.63) |
| Mar 7, 2022 | David Bruce Milne | Director | Buy | $4K (5,768 @ $0.62) |
| Mar 7, 2022 | David Bruce Milne | Director | Buy | $30K (50,000 @ $0.61) |
| Mar 4, 2022 | David Bruce Milne | Director | Buy | $32K (50,000 @ $0.64) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.